EpimAb Biotherapeutics

company

Number of Lead Investors

Number of Investors

EpimAb Biotherapeutics is funded by 16 investors. MiraeAsset Financial Group and CMB International Capital Corporation are the most recent investors.

Investor Name	Lead Investor	Funding Round
MiraeAsset Financial Group	Yes	Series C
CMB International Capital Corporation	Yes	Series C
Oriza Seed Capital (Oriza Yuandian)	Yes	Series A
Hidragon Capital	-	Series C
Adrian Cheng	-	Series C
Cormorant Asset Management	-	Series C
Decheng Capital	-	Series C
Hony Capital	-	Series C
Octagon Capital Advisors	-	Series C
SDIC Fund Management	-	Series C
Shangbay Capital	-	Series C
Sherpa Venture Capital	-	Series C
Yanchuang Capital	-	Series C
South China Venture Capital	-	Series B
3E Bioventures	-	Series A
Trend Investment Group	-	Series A